Search
CR Double-Crane: Allocates RMB 40 Million for Phase Two of China Resources Pharmaceutical Industry Investment Fund
2025-07-17 /
Read about 0 minute
Author：小编
CR Double-Crane has announced its intention to collaboratively launch the China Resources Pharmaceutical (Chengdu) Innovation Investment Fund alongside relevant parties, aiming to raise a total of RMB 1 billion. As part of this initiative, CR Double-Crane will contribute RMB 40 million, constituting a 4% share in the fund. The primary objectives of this fund are to refine the company's strategic positioning, foster innovation and transformation, bolster resource allocation efficacy, and generate investment returns. These endeavors are aimed at reinforcing CR Double-Crane's sustainable growth and profitability over the medium to long term.
-
C114 Communication Network -
Communication Home
7 X 24 Track global technological trends
